| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/26/2005 | CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 07/21/2005 | WO2005066161A1 Tricyclic steroid hormone nuclear receptor modulators |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005066151A2 Histone deacetylase inhibitors |
| 07/21/2005 | WO2005065680A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 07/21/2005 | WO2005065154A2 Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same |
| 07/21/2005 | WO2005042497A3 Benzimidazoles useful as modulators of ion channels |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone |
| 07/21/2005 | CA2547785A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 07/20/2005 | EP1554254A1 Novel compounds |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/19/2005 | US6919365 Also oxazolidinediones; excellant enzyme inhibitors of chymase and/or tryptase; antiallergens; antiinflammatory agents; vascular circulatory system disease; vision defects, antidiabetic and -arthritic agents; pancreatitis; hepatitis |
| 07/19/2005 | US6919331 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 07/14/2005 | WO2005064006A1 OPTICALLY ACTIVE, HETEROAROMATIC β-HYDROXY ESTERS, PROCESSES FOR THEIR PREPARATION FROM β-KETO ESTERS AND PROCESSES FOR THE PREPARATION OF THESE β-KETO ESTERS |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154040 Nitrogen-containing heteroaryl derivatives |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | CA2546981A1 Optically active, heteroaromatic .beta.-hydroxy esters, processes for their preparation from .beta.-keto esters and processes for the preparation of these .beta.-keto esters |
| 07/13/2005 | EP1553089A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551826A1 Hydantoine derivatives and their use as tace inhibitors |
| 07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 07/13/2005 | EP1551397A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/13/2005 | CN1639112A Substituted amides active at the cannabinoid-1 receptor |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916836 Compounds and methods for use thereof in the treatment of viral infections |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/12/2005 | CA2143040C The use of benzazoles as uv absorbers, new benzazoles and a process for their preparation |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 07/07/2005 | WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 07/07/2005 | US20050148646 Dicationic triaryl analogs as anti-protozoan agents |
| 07/07/2005 | US20050148643 Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148618 Tricyclic n-acyl compounds |
| 07/07/2005 | US20050147633 Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549598A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | US20050143439 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548657A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer |
| 06/29/2005 | EP1546120A2 Pharmaceutical compositions for treatment of parkinson's disease |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1339400B1 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections |
| 06/29/2005 | EP1272473B1 Process for preparing substituted benzimidazole compounds |
| 06/29/2005 | CN1633435A Tricyclic n-acyl compounds |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/28/2005 | US6911462 Benzimidazole compounds for regulating IgE |
| 06/23/2005 | WO2005056719A1 Organic element for electroluminescent devices |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005040129A3 Ccr3 receptor antagonists |
| 06/23/2005 | WO2005037272A8 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |